Skip to main content
SpringerLink
Log in

Cabozantinib associated with excessive toxicity for salivary gland cancer in phase II trial

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • van Boxtel W, et al. Excessive toxicity of cabozantinib in a phase II study in patients with recurrent and/or metastatic salivary gland cancer. European Journal of Cancer : 14 Dec 2021. Available from: URL: http://doi.org/10.1016/j.ejca.2021.10.033

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cabozantinib associated with excessive toxicity for salivary gland cancer in phase II trial. Reactions Weekly 1887, 9 (2022). https://doi.org/10.1007/s40278-022-07674-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-07674-3

Search

Navigation